{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T10:17:59Z","timestamp":1756462679767,"version":"3.37.3"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T00:00:00Z","timestamp":1736121600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ejogrb.2025.01.012","type":"journal-article","created":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T17:34:24Z","timestamp":1736530464000},"page":"75-80","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Clear cell borderline ovarian tumor: A retrospective study and literature review"],"prefix":"10.1016","volume":"306","author":[{"given":"Yang","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Congwei","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yonglan","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junjun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9112-1021","authenticated-orcid":false,"given":"Yang","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ejogrb.2025.01.012_b0005","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/00125480-199909000-00002","article-title":"Ovarian tumors of borderline malignancy (tumors of low malignant potential): a critical appraisal","volume":"6","author":"Prat","year":"1999","journal-title":"Adv Anat Pathol"},{"journal-title":"WHO Classification of Tumours of Female Reproductive Organs","year":"2020","author":"Kurman","key":"10.1016\/j.ejogrb.2025.01.012_b0010"},{"issue":"6","key":"10.1016\/j.ejogrb.2025.01.012_b0015","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1097\/IGC.0b013e3182534acf","article-title":"Management and prognosis of clear cell borderline ovarian tumor","volume":"22","author":"Uzan","year":"2012","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"10.1016\/j.ejogrb.2025.01.012_b0020","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1245\/s10434-021-10776-7","article-title":"Clear cell borderline ovarian tumor: clinical characteristics, prognosis, and management","volume":"29","author":"Ricotta","year":"2022","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejogrb.2025.01.012_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijgo.2013.10.001","article-title":"Staging classification for cancer of the ovary, fallopian tube, and peritoneum","volume":"124","author":"Prat","year":"2014","journal-title":"Int J Gynaecol Obstet"},{"issue":"1","key":"10.1016\/j.ejogrb.2025.01.012_b0030","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/modpathol.3800492","article-title":"Expression of hepatocyte nuclear factor-1beta (HNF-1beta) in clear cell tumors and endometriosis of the ovary","volume":"19","author":"Kato","year":"2006","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.ejogrb.2025.01.012_b0035","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/PAS.0000000000000085","article-title":"Frequent expression of napsin A in clear cell carcinoma of the endometrium: potential diagnostic utility","volume":"38","author":"Fadare","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"10.1016\/j.ejogrb.2025.01.012_b0040","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.humpath.2015.03.008","article-title":"Napsin A is frequently expressed in clear cell carcinoma of the ovary and endometrium","volume":"46","author":"Iwamoto","year":"2015","journal-title":"Hum Pathol"},{"issue":"12","key":"10.1016\/j.ejogrb.2025.01.012_b0045","doi-asserted-by":"crossref","first-page":"e232","DOI":"10.1371\/journal.pmed.0050232","article-title":"Ovarian carcinoma subtypes are different diseases: implications for biomarker studies","volume":"5","author":"K\u00f6bel","year":"2008","journal-title":"PLoS Med"},{"issue":"3","key":"10.1016\/j.ejogrb.2025.01.012_b0050","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.ygyno.2021.06.033","article-title":"Clear cell carcinoma of the ovary: Epidemiology, pathological and biological features, treatment options and clinical outcomes","volume":"162","author":"Gadducci","year":"2021","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ejogrb.2025.01.012_b0055","first-page":"230","article-title":"Borderline clear cell adenofibroma of the ovary associated with ovarian endometriosis: a case report","volume":"33","author":"Vasilakaki","year":"2012","journal-title":"Eur J Gynaecol Oncol"},{"key":"10.1016\/j.ejogrb.2025.01.012_b0060","doi-asserted-by":"crossref","first-page":"94","DOI":"10.7150\/jca.2.94","article-title":"Pathogenesis of ovarian clear cell adenofibroma, atypical proliferative (borderline) tumor, and carcinoma: clinicopathologic features of tumors with endometriosis or adenofibromatous components support two related pathways of tumor development","volume":"2","author":"Zhao","year":"2011","journal-title":"J Cancer"},{"issue":"4","key":"10.1016\/j.ejogrb.2025.01.012_b0065","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3892\/mco.2021.2237","article-title":"Clear cell borderline tumor without fibromatous component: pathological and literature review and report of two cases","volume":"14","author":"Hada","year":"2021","journal-title":"Mol Clin Oncol"},{"issue":"3","key":"10.1016\/j.ejogrb.2025.01.012_b0070","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.ygyno.2005.12.039","article-title":"Cystic clear cell tumor of borderline malignancy of the ovary lacking fibromatous components: report of two cases and a possible new histological subtype","volume":"101","author":"Suzuki","year":"2006","journal-title":"Gynecol Oncol"},{"issue":"10","key":"10.1016\/j.ejogrb.2025.01.012_b0075","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/j.asjsur.2022.05.149","article-title":"Ovarian clear cell borderline tumor: A systemic review","volume":"45","author":"Wang","year":"2022","journal-title":"Asian J Surg"},{"issue":"1","key":"10.1016\/j.ejogrb.2025.01.012_b0080","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1006\/gyno.2002.6711","article-title":"Long-term survival and patterns of care in women with ovarian tumors of low malignant potential","volume":"86","author":"Trimble","year":"2002","journal-title":"Gynecol Oncol"},{"issue":"12","key":"10.1016\/j.ejogrb.2025.01.012_b0085","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1002\/1097-0142(19851215)56:12<2922::AID-CNCR2820561233>3.0.CO;2-L","article-title":"Benign and borderline clear cell adenofibromas of the ovary","volume":"56","author":"Bell","year":"1985","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.ejogrb.2025.01.012_b0090","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S1658-3876(10)50026-8","article-title":"Borderline clear cell adenofibroma with extensive hemorrhagic necrosis","volume":"3","author":"Liu","year":"2010","journal-title":"Hematol Oncol Stem Cell Ther"},{"issue":"2","key":"10.1016\/j.ejogrb.2025.01.012_b0095","first-page":"87","article-title":"Ovarian clear cell adenofibroma of borderline malignancy. A case report","volume":"38","author":"Katsube","year":"1989","journal-title":"Hiroshima J Med Sci"},{"issue":"2","key":"10.1016\/j.ejogrb.2025.01.012_b0100","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ygyno.2018.09.004","article-title":"Analysis of oncologic and reproductive outcomes after fertility-sparing surgery in apparent stage I adult ovarian granulosa cell tumors","volume":"151","author":"Wang","year":"2018","journal-title":"Gynecol Oncol"},{"issue":"5","key":"10.1016\/j.ejogrb.2025.01.012_b0105","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1097\/IGC.0b013e31821bec6b","article-title":"Recommendations of the Fertility Task Force of the European Society of Gynecologic Oncology about the conservative management of ovarian malignant tumors","volume":"21","author":"Morice","year":"2011","journal-title":"Int J Gynecol Cancer"},{"issue":"6","key":"10.1016\/j.ejogrb.2025.01.012_b0110","first-page":"729","article-title":"Unusual cystadenofibromas: endometrioid, mucinous, and clear cell types","volume":"54","author":"Kao","year":"1979","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.ejogrb.2025.01.012_b0115","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1002\/1097-0142(19840301)53:5<1156::AID-CNCR2820530522>3.0.CO;2-2","article-title":"Ovarian clear cell adenofibromatous tumors. Benign, of low malignant potential, and associated with invasive clear cell carcinoma","volume":"53","author":"Roth","year":"1984","journal-title":"Cancer"}],"container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211525000120?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211525000120?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T05:52:53Z","timestamp":1740376373000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211525000120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":23,"alternative-id":["S0301211525000120"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2025.01.012","relation":{},"ISSN":["0301-2115"],"issn-type":[{"type":"print","value":"0301-2115"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clear cell borderline ovarian tumor: A retrospective study and literature review","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2025.01.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}